Literature DB >> 18406555

Radiological detectability of minute hepatic venous invasion in hepatocellular carcinoma.

Akihiro Nishie1, Kengo Yoshimitsu, Hiroyuki Irie, Tsuyoshi Tajima, Masakazu Hirakawa, Kousei Ishigami, Yasuhiro Ushijima, Daisuke Okamoto, Yunosuke Nishihara, Akinobu Taketomi, Hiroshi Honda.   

Abstract

OBJECTIVE: To determine if minute hepatic venous invasion in hepatocellular carcinoma (HCC) can be diagnosed radiologically.
MATERIALS AND METHODS: CT hepatic arteriography (CTHA) and CT arterioportography (CTAP) of 95 cases with HCCs were examined. Histopathology after surgery has been the gold standard in all patients. Based on the presence of microscopic portal venous invasion (MPVI) and microscopic hepatic venous invasion (MHVI), the cases were classified into four groups as follows: Group vp0vv0, negative MPVI and MHVI; Group vp1vv0, positive MPVI and negative MHVI; Group vp0vv1, negative MPVI and positive MHVI; Group vp1vv1, positive MPVI and MHVI. An area showing low attenuation on CTAP and high attenuation on CTHA around the tumor was defined as an area of peritumoral hemodynamic change (APTHC). The shape and size of APTHC were compared between Groups vp0vv1 and vp0vv0 or between Groups vp1vv1 and vp1vv0. The ratio of APTHC volume to tumor volume (RAT) was employed as an indicator of APTHC size. Each comparison was also made independently when tumor diameter was limited to either less than 3 cm or 3 cm or more.
RESULTS: Three types of APTHC were identified: wedge-shaped, belt-shaped or irregular, and linear. No significant difference in the frequency of each type of APTHC was observed between Groups vp0vv1 and vp0vv0 or between Groups vp1vv1 and vp1vv0. There was no significant difference in RAT between Groups vp0vv1 and vp0vv0 or between Groups vp1vv1 and vp1vv0, unrelated to tumor size.
CONCLUSIONS: The presence of minute hepatic venous invasion in HCC is difficult to determine even on combined CTHA and CTAP.

Entities:  

Mesh:

Year:  2008        PMID: 18406555     DOI: 10.1016/j.ejrad.2008.02.021

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

1.  Radiological assessment of hepatic vein invasion by hepatocellular carcinoma using combined computed tomography hepatic arteriography and computed tomography arterial portography.

Authors:  Akihiro Nishie; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa; Yasuhiro Ushijima; Daisuke Kakihara; Daisuke Okamoto; Nobuhiro Fujita; Akinobu Taketomi; Kengo Yoshimitsu; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2010-07-27       Impact factor: 2.374

2.  Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI?

Authors:  N Griffin; H Addley; E Sala; A S Shaw; L A Grant; H Eldaly; S E Davies; T Prevost; G J Alexander; D J Lomas
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

3.  Hemodynamic Alteration in the Liver in Acute Hepatitis: A Quantitative Evaluation Using Computed Tomographic Perfusion.

Authors:  Akihiro Nishie; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Yuichiro Kubo; Keisuke Ishimatsu; Daisuke Tsurumaru; Motoyuki Kohjima; Kousei Ishigami
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

4.  Liver Imaging and Data System (LI-RADS) Version 2018 and Other Imaging Features in Intrahepatic Cholangiocarcinoma in Chinese Adults with vs. without Chronic Hepatitis B Viral Infection.

Authors:  Ying-Ying Liang; Shuo Shao; Sichi Kuang; Jingbiao Chen; Jing Zhou; Bingjun He; Linqi Zhang; Yao Zhang; Kathryn J Fowler; Jin Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2021-03-04

5.  Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based Retrospective Study.

Authors:  Meng Li; Yongjie Xin; Sirui Fu; Zaiyi Liu; Yong Li; Baoshan Hu; Shuting Chen; Changhong Liang; Ligong Lu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.